logo

For the Inventor, By the Inventor

Kadoma, Japan

Kunio Hayashi

This inventor holds 6 USPTO granted patents. Top assignee: Shionogi Company Limited. Active years: 1986-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kunio Hayashi. Retrieved from https://idiyas.com/inventor/kunio-hayashi-itjejmht

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 66.7

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 63(Granted Patents)


Location History:

  • Osaka, JP (1986)
  • Kadoma, JP (1993 - 2012)

Company Filing History:

goldMedal6 out of 1,001 
 
Shionogi Company Limited
 patents

Years Active: 1986-2012

Loading Chart...
6 patents (USPTO):Explore Patents
1. 8124625 - Method of enhancing the expression of apolipoprotein AI using olefin derivatives (2012-02-28),
2. 8053445 - Utilities of olefin derivatives (2011-11-08),
3. 5272268 - Dipeptide derivatives (1993-12-21),
4. 5223615 - Dipeptide derivatives (1993-06-29),
5. 5194608 - Dipeptide derivatives (1993-03-16),
6. 4595767 - 1,4-benzodioxine and 1,4-benzodioxine derivatives and production thereof (1986-06-17),

Title: Kunio Hayashi: Innovator in Apolipoprotein Research

Introduction

Kunio Hayashi is a notable inventor based in Kadoma, Japan. He has made significant contributions to the field of biochemistry, particularly in the enhancement of apolipoprotein AI expression. With a total of 6 patents to his name, Hayashi's work has implications for pharmaceutical advancements.

Latest Patents

Hayashi's latest patents include a method of enhancing the expression of apolipoprotein AI using olefin derivatives. The compounds he has developed are designed to enhance the expression of apoAI, featuring specific chemical structures that include phenyl, naphthyl, and various aromatic heterocyclic groups. These compounds are disclosed as prodrugs or pharmaceutically acceptable salts, showcasing their potential utility in medical applications.

Career Highlights

Hayashi is currently associated with Shionogi Company Limited, where he continues to innovate in the field of biochemistry. His research focuses on the development of compounds that can significantly impact health and medicine.

Collaborations

Some of his notable coworkers include Masuhisa Nakamura and Naofumi Hashimoto. Their collaborative efforts contribute to the advancement of research in the pharmaceutical industry.

Conclusion

Kunio Hayashi's work exemplifies the intersection of innovation and healthcare, with his patents paving the way for future developments in the enhancement of apolipoprotein AI expression. His contributions are vital to the ongoing research in biochemistry and pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…